Rad AI, a leading company in generative AI for healthcare, has successfully raised $50 million in a Series B financing round, bringing its total capital to over $80 million. The funding was led by Khosla Ventures and included contributions from several notable investors such as WiL, ARTIS Ventures, OCV Partners, Kickstart Fund, and Gradient Ventures. Rad AI is renowned for its AI solutions that are currently used by a significant portion of US health systems and top radiology practices to enhance radiology reporting and patient care.
The company's primary offering, Rad AI Reporting, is an advanced AI-powered tool that revolutionises radiology reporting by automating the generation of reports. This allows radiologists to tailor reports in their style while significantly reducing the time spent on dictation, which traditionally occupies about 75% of their workday. Additionally, Rad AI has introduced Rad AI Continuity, a solution that streamlines patient follow-ups, which has been adopted by numerous large health systems. These innovations collectively serve nearly 50 million patients each year, demonstrating substantial positive impacts on healthcare efficiency and patient outcomes.
Rad AI's technology notably alleviates physician burnout by automating routine tasks such as dictation and follow-up management, enabling physicians to concentrate more on patient care. The adoption of Rad AI's solutions has led to remarkable improvements in healthcare delivery, including increased follow-up rates for critical findings, faster report creation, and reduced report errors. These advancements underscore Rad AI's significant role in enhancing the quality of healthcare through AI-driven solutions, supported by the recent strategic investment to solidify its leadership in the field.
Click here to read the original news story.